Biglycan: A novel modulator of osteoblast differentiation

Biglycan：成骨细胞分化的新型调节剂

• 批准号: 7140327
• 负责人: MITSUO YAMAUCHI
• 金额: $ 15.68万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-09-01 至 2008-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7140327
• 关键词: SDS polyacrylamide gel electrophoresis; bone morphogenetic proteins; cell differentiation; chondroitin sulfates; immunoprecipitation; intermolecular interaction; messenger RNA; molecular cloning; normal ossification; osteoblasts; proteoglycan

DESCRIPTION (provided by applicant): Biomineralization is a complex process orchestrated by cells, growth factors and a number of key extracellular matrix molecules, and the elucidation of factors that control the formation and maintenance of the functional mineralized matrix is critical in understanding the cause of mineralized tissue disorders. Recent studies have indicated that biglycan (BGN), a member of small leucine rich matrix proteoglycans, plays a role in bone formation/matrix mineralization by modulating osteoblast differentiation. However, the mechanisms are not well understood. This exploratory research is intended to seek a novel modulatory role of BGN in osteoblast differentiation and subsequent matrix mineralization. The hypothesis to be tested is that BGN promotes osteoblast differentiation/matrix mineralization by through its specific interaction with bone morphogenetic protein (BMP)-2. To test this hypothesis the following specific aims will be pursued: (1) to determine the binding specificity of BGN to BMP-2; (2) to investigate the effects of BGN on BMP-2-mediated osteoblastic cell differentiation; and (3) to determine the effects of BGN and BMP-2 on osteoblastic cell differentiation and matrix mineralization using osteoblastic MC3T3-E1 cell-derived clones expressing lower levels of BGN. The data obtained from this study may provide insights into a novel pathway of matrix-modulated osteoblast differentiation and mineralized tissue formation.

描述（由申请人提供）：生物矿化是一个由细胞、生长因子和许多关键细胞外基质分子协调的复杂过程，阐明控制功能性矿化基质形成和维持的因子对于理解矿化组织疾病的原因至关重要。最近的研究表明，双糖蛋白聚糖（BGN），一个小亮氨酸丰富的基质蛋白聚糖的成员，通过调节成骨细胞分化在骨形成/基质矿化中发挥作用。然而，其机制并不十分清楚。本研究旨在探索BGN在成骨细胞分化和随后的基质矿化中的新的调节作用。待检验的假设是BGN通过其与骨形态发生蛋白（BMP）-2的特异性相互作用促进成骨细胞分化/基质矿化。为了检验这一假设，将追求以下具体目标：（1）确定BGN与BMP-2的结合特异性;（2）研究BGN对BMP-2介导的成骨细胞分化的影响;和（3）使用表达较低水平BGN的成骨MC 3 T3-E1细胞衍生克隆确定BGN和BMP-2对成骨细胞分化和基质矿化的影响。从这项研究中获得的数据可能会提供一个新的途径，基质调节成骨细胞分化和矿化组织形成的见解。